ReVision Implant wins FDA breakthrough nod for vision-restoring BCI
March 9, 2026
ReVision Implant announced today that it received FDA breakthrough device designation for its Occular visual cortical prosthesis.
ReVision Implant announced today that it received FDA breakthrough device designation for its Occular visual cortical prosthesis.
A research team led by Professor Jaehyuk Cho from the Department of Software Engineering at Jeonbuk National University in South Korea, have developed an innovative model, named BiT-MAML, aimed at tackling inter-patient variability in BG prediction.
Researchers at Kiel University (CAU) have now developed a novel 3D material on which human brain cells can grow and exchange signals in the lab.
New product line extends options to better meet patient needs
LifeVac is approved for use as a single-use, non-powered, non-invasive airway clearance device.